Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cellectar Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 46 | 1 | 40 | −5 |
| Shares | 12.5M | 142.4K | 7.32M | −5.02M (−40.7%) |
| Value | $14.9M | $170.0K | $6.77M | −$7.93M (−53.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Cellectar Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Franklin Resources Inc | 142,400 | $132.0K | 0.00% |
| Price T Rowe Associates Inc | 41,700 | $39.0K | 0.00% |
| Two Sigma Securities, LLC | 25,074 | $23.0K | 0.00% |
| Modera Wealth Management, LLC | 20,000 | $19.0K | 0.00% |
| Commerce Bank | 14,280 | $13.0K | 0.00% |
| LPL Financial LLC | 14,000 | $13.0K | 0.00% |
| Scotia Capital Inc. | 11,213 | $10.0K | 0.00% |
| Advisory Services Network, LLC | 10,000 | $9.00K | 0.00% |
Sold out (13)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Consonance Capital Management LP | 3,913,000 | $4.66M |
| Sabby Management, LLC | 426,561 | $508.0K |
| Gsa Capital Partners LLP | 297,653 | $354.0K |
| FNY Investment Advisers, LLC | 220,321 | $262.0K |
| PVG Asset Management Corp | 193,510 | $230.3K |
| Envestnet Asset Management Inc | 104,385 | $124.0K |
| Virtu Financial LLC | 49,780 | $59.0K |
| Creative Planning | 30,000 | $36.0K |
| Moloney Securities Asset Management, LLC | 18,615 | $22.0K |
| Royal Bank of Canada | 15,000 | $18.0K |
| ExodusPoint Capital Management, LP | 14,452 | $17.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 7,563 | $9.00K |
| Bank of America Corp | 22 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 142,400 | $170.0K |